Board Meeting6 Nov 2026, 06:55 pm
Aarey Drugs Board Meeting on Nov 14 to Approve Q2 FY27 Results
AI Summary
Aarey Drugs & Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. Additionally, the board will discuss any other business with the Chairman's consent. In line with SEBI regulations, the company has closed its trading window from October 1, 2026, which will reopen 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To approve Unaudited Financial Results for Q2 FY27.
- Limited Review Report for the period will also be considered.
- Trading window closed from October 1, 2026.
- Trading window to reopen 48 hours post results announcement.
Price Impact
More from AAREYDRUGS